Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$4.7 - $7.24 $58,308 - $89,819
-12,406 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$6.81 - $10.93 $84,484 - $135,597
12,406 New
12,406 $85,000
Q4 2020

Feb 16, 2021

SELL
$4.58 - $7.14 $142,836 - $222,675
-31,187 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$4.19 - $6.69 $398,728 - $636,633
-95,162 Reduced 75.32%
31,187 $169,000
Q2 2020

Aug 14, 2020

BUY
$2.97 - $5.22 $375,256 - $659,541
126,349 New
126,349 $660,000
Q1 2020

May 15, 2020

SELL
$2.67 - $4.97 $68,114 - $126,789
-25,511 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$2.93 - $4.5 $74,747 - $114,799
25,511 New
25,511 $103,000
Q4 2018

Feb 14, 2019

SELL
$4.8 - $11.6 $49,665 - $120,025
-10,347 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$9.05 - $10.95 $93,640 - $113,299
10,347 New
10,347 $100,000
Q2 2018

Aug 14, 2018

SELL
$10.2 - $13.9 $159,120 - $216,840
-15,600 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$12.65 - $18.85 $183,703 - $273,739
-14,522 Reduced 48.21%
15,600 $203,000
Q4 2017

Feb 14, 2018

BUY
$17.45 - $25.6 $525,628 - $771,123
30,122
30,122 $539,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.